15/09/2006 - Chinese researchers may have solved the problem of vaccine shortage in the event of an avian influenza pandemic after a clinical trial showed that their formulation containing the whole H5N1 virus instead of virus particles resulted in an affective immune response at lower doses.
Link to Article
In-Pharmatechnologist.com
|
|
||||||||
|
This Month
Month Archive
|
Whole-virus formulation leads to dose-sparing H5N1 vaccine
No comments found.
|
Search
Links
|
||||||